Measles vaccination before nine months

Tropical Medicine and International Health

Volumn 3, Issue 9, 1998, Pages 751-756

  George, Kuryan ^a   Joseph, Abraham ^a   Muliyil, Jayaprakash ^a   Abraham, Sulochana ^a   Bhattacharji, Sara ^a   John, K R ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Edmonston Zagreb; Measles vaccine; Mortality

Indexed keywords

MEASLES VACCINE;

CHILD HEALTH; HEALTH CARE; IMMUNIZATION; MEASLES; VACCINATION;

ARTICLE; CHILD; HUMAN; INDIA; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; TREATMENT PLANNING; VACCINATION;

AGE DISTRIBUTION; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INDIA; INFANT; INFANT MORTALITY; MALE; MEASLES; MEASLES VACCINE; POPULATION SURVEILLANCE; RISK FACTORS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; VACCINATION;

EID: 0031660451     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1998.00295.x     Document Type: Article

References (35)

1. Aaby P, Jensen TG, Beck HL et al. (1988) Trial of high-dose Edmonston Zagreb vaccine in Guinea Bissau: Protective efficacy. Lancet ii, 809-811.
2. Aaby P, Samb B, Simondon F et al. (1993a) Divergent mortality for male and female recipients of low-titer and high-titer measles vaccines in rural Senegal. American Journal of Epidemiology 138, 746-755.
3. Aaby P, Knudsen K, Whittle H et al. (1993b) Long term survival after Edmonston-Zagreb vaccination in Guinea-Bissau: Increased female mortality rate. The Journal of Pediatrics 122, 904-908.
4. Aaby P, Andersen M, Sodemann M et al. (1993c) Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age. British Medical Journal 307, 1308-1311.
5. Aaby P, Samb B, Simondon F et al. (1994a) Sex-specific differences in mortality after high-titre measles immunization in rural Senegal. Bulletin of the World Health Organization 72, 761-770.
6. Aaby P, Lisse IM, Whittle H et al. (1994b) Long term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up. Epidemiology and Infection 112, 413-420.
7. Black FL, Berman LL, Borogne JM et al. (1986) Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody. American Journal of Epidemiology 124, 442-452.
8. Centers for Disease Control (1990) Case definitions for Public Health Surveillance. Mortality and Morbidity Weekly Report 39 (No-RR 13), 23.
9. Clemens JD, Stanton BF, Chakraborty J et al. (1988) Measles vaccination and childhood mortality in rural Bangladesh. American Journal of Epidemiology 128, 1380-1339.
10. Fauveau V, Chakraborty J, Sardar AM et al. (1991) Measles among under 9 month-olds in rural Bangladesh: Its significance for age at immunization. Bulletin of the World Health Organization 69, 67-77.
11. Garenne M & Aaby P (1990) Pattern of exposure and measles mortality in Senegal. Journal of Infectious Disease 161, 1088-1094.
12. Garenne M, Leroy O, Beau JP et al. (1991) Child mortality after high titre measles vaccine: Prospective study in Senegal. Lancet ii, 993-996.
13. Halsey NA (1983) The optimal age for administering measles vaccine in tropical countries: recent advances in immunization. A bibliographic review. Paho Scientific Publication No 451, 4-17.
14. Halsey NA, Bolus R, Mode F et al. (1985) Response to measles vaccine in Haitian infants 6-12 months old. New England Journal of Medicine 313, 544-549.
15. Hayden GF, Sato PA, Wright PF et al. (1989) Progress in worldwide control and elimination of disease through immunization. Journal of Paediatrics 114, 520-527.
16. Henderson AH, Keja JK, Hayden G et al. (1988) Immunizing the children of the world: Progress and prospects. Bulletin of the World Health Organization 66, 535-543.
17. Holt EA, Boulos R, Halsey NA et al. (1990) Childhood survival in Haiti: protective effect of measles vaccination. Pediatrics 85, 188-194.
18. Hull HF, Williams P & Oldfield F (1983) Measles mortality and vaccine efficacy in rural West Africa. Lancet i, 972-975.
19. Job JS, John TJ & Joseph A (1984) Antibody response to measles immunization in India. Bulletin of the World Health Organization 62, 737-741.
20. Joseph A, Joseph KS & Kamaraj K (1991) Use of Computers in Primary Health Care. International Journal of Health Sciences 2, 93-101.
21. Kasongo Project Team (1981) Influence of measles vaccination on survival pattern of 7-35 month-old children in Kasongo, Zaire. Lancet i, 764-767.
22. Khanum S, Uddin N, Garlick H et al. (1987) Comparison of Edmonston Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection. Lancet ii, 150-153.
23. Koenig VC & Coovadia HM (1983) Age-specific occurrence rate of measles in urban, periurban and rural environments: implications for the time of vaccination. Lancet ii, 324-326.
24. Nokes DJ, McLean AR, Anderson RM et al. (1990) Measles immunization strategies for countries with high transmission: interim guidelines predicted using a mathematical model. International Journal of Epidemiology 19, 703-710.
25. Sinha WP (1981) Measles in children less then six months of age: an epidemiological study. Journal of Tropical Paediatrics 27, 120-122.
26. Stanton BF & Clemens JD (1988) Inference of gender on determinants of urban childhood mortality in Bangladesh. International Journal of Epidemiology 17, 129-185.
27. Taylor WR, Rati K, Mambu MD et al. (1988) Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life. American Journal of Epidemiology 127, 788-794.
28. Van Ginneken JK & Muller AS (1984) Maternal and Child Health in Rural Kenya. Croom Helm.
29. Velema JP, Alihonou EM, Gandacho T et al. (1991) Childhood mortality among users and non-users of primary health care in a rural west African community. International Journal of Epidemiology 20, 474-479.
30. Whittle HC, Rowland MGM, Mann GF et al. (1984) Immunization of 4-6 month old Gambian infants with Edmonston-Zagreb vaccine. Lancet ii, 834-837.
31. Whittle HC, Mann G, Eccles M et al. (1988a) Effect of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet i, 963-966.
32. Whittle HG, Hanlon P, O'Neill K et al. (1988b) Trial of high dose Edmonston Zagreb vaccine in the Gambia: Antibody response and side effects. Lancet ii, 811-814.
33. Wilkins J & Wehrle PF (1979) Additional evidence against measles vaccine administered to infants less than 12 months of age: Alteted immune response following active/passive immunization. Journal of Paediatrics 94, 865-869.
34. World Health Organization (1986) Immunization before 9 months of age? Position statement by the expanded program on immunization of the World Health Organization. Lancet ii, 1356.
35. World Health Organization/EPI, Research & Development Group (1992) Expanded program on Immunization: Safety of high titre measles vaccines. Weekly Epidemiological Research 48, 357-364.